Condition: Synovial Sarcoma · Malignant Peripheral Nerve Sheath Tumor (MPNST) · Neuroblastoma (NBL) · Sponsor: USWM CT, LLC
This is a pediatric basket study to investigate the safety and efficacy of afamitresgene autoleucel in HLA-A\*02 eligible and MAGE-A4 positive subjects aged 2-17 years of age with advanced cancers.
This description comes directly from the study's public registry record.
Contact details are listed per location below or on the registry record.
Always discuss trial participation with your own doctor first.
| Stanford University | Palo Alto, California, United States | Recruiting |
| National Institutes of Health | Bethesda, Maryland, United States | Recruiting |
| Dana Farber Cancer Institute | Boston, Massachusetts, United States | Not Yet Recruiting |
| Washington University | St Louis, Missouri, United States | Recruiting |
| Memorial Sloan Kettering Kids | New York, New York, United States | Not Yet Recruiting |
| Duke University School of Medicine | Durham, North Carolina, United States | Not Yet Recruiting |
| Cincinnati Children's Hospital Medical Center | Cincinnati, Ohio, United States | Recruiting |
| Children's Hospital of Philedephia | Philadelphia, Pennsylvania, United States | Recruiting |
| Seattle Children's Hospital | Seattle, Washington, United States | Not Yet Recruiting |
| University of Wisconsin Cancer Center | Madison, Wisconsin, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05642455